HomeProductsBioactive CompoundsMAPK/ERK PathwayERKUlixertinib
Chemical structure of CAS 869886-67-9

Ulixertinib

CAS No.869886-67-9
MDL No.MFCD22628898
MFC21H22Cl2N4O2
MW433.30
InChI KeyKSERXGMCDHOLSS-LJQANCHMSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.869886-67-9
Product NameUlixertinib

Biological Targets

MAPK3·MAPK1

Associated Conditions

acute myeloid leukemia·neoplasm·Paraganglioma·pancreatic carcinoma·Uveal Melanoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib).

Molecular cancer therapeutics • Vol. 16, Issue 11 • 2017
PMID: 28939558DOI: 10.1158/1535-7163.MCT-17-0456

Structure-Guided Design of Highly Selective and Potent Covalent Inhibitors of ERK1/2.

Journal of medicinal chemistry • Vol. 58, Issue 11 • 2015
PMID: 25977981DOI: 10.1021/acs.jmedchem.5b00466

Documentation

Similar Products